Research Article
Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors
Table 1
Clinical characteristics of patients with Xp11.2 translocation RCC.
| | Value | % |
| | Gender | | Male | 12 | 50% | | Female | 12 | 50% | | Age (year) | | | | Symptoms at onset | | Symptomatic | 11 | 45.80% | | Asymptomatic | 13 | 54.20% | | Location | | Right | 15 | 62.50% | | Left | 9 | 37.50% | | Tumor size (cm) | | | | Lymph node metastasis | | Positive | 11 | 45.80% | | Negative | 13 | 54.20% | | Distant metastasis | | Positive | 6 | 25.00% | | Negative | 18 | 75.00% | | Tumor thrombus of IVC | | Positive | 5 | 20.80% | | Negative | 19 | 79.20% | | Surgical treatment | | No surgery | 2 | 8.30% | | Partial | 6 | 25.00% | | Radical | 16 | 66.70% | | Additional treatment | | Interleukin-1 | 6 | 25.00% | | Targeted drug | 10 | 41.67% |
|
|
RCC: renal cell carcinoma; IVC: inferior vena cava.
|